Introduction: This review evaluates the novel strategy of treating Alzheimer's and Parkinson's
disease (AD and PD) withdrugs that initially have been developed to treat type 2 diabetes …

Parkinson's disease (PD) is the second most common neurodegenerative disease after
Alzheimer's disease (AD). Genetic predisposition and immune dysfunction are involved in …

Neurological disorders are a diverse group of conditions that affect the nervous system and
include neurodegenerative diseases (Alzheimer's disease, multiple sclerosis, Parkinson's …

Parkinson's disease is characterized by its distinct pathological features; loss of dopamine
neurons in the substantia nigra pars compacta and accumulation of Lewy bodies and Lewy …

The novel antibiotic-exploiting strategy in the treatment of Alzheimer's (AD) and Parkinson's
(PD) disease has emerged as a potential breakthrough in the field. The research in animal …

Parkinson's disease (PD) is a highly heterogeneous and therefore a possible cause of
translation failure of drugs from animal testing to human treatments can be because existing …

Abstract Background/Objective: The purpose of this study was to evaluate the prevalence
and severity of skin involvement in children with IgA vasculitis (IgAV) and its relationship with …

Introduction: Gastrointestinal dyshomeostasis is investigated in the context of metabolic
dysfunction, systemic, and neuroinflammation in Alzheimer's disease. Dysfunctional …

A recent article by Ghosh et al. entitled" Optimization of intracerebroventricular
streptozotocin dose for the induction of neuroinflammation and memory impairments in rats" …

Cognitive deficit is a frequent non-motor symptom in Parkinson's disease (PD) with an
unclear pathogenesis. Recent research indicates possible involvement of insulin resistance …